These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

710 related items for PubMed ID: 26100618

  • 1. Cutaneous Manifestations in Dermatomyositis: Key Clinical and Serological Features-a Comprehensive Review.
    Muro Y, Sugiura K, Akiyama M.
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):293-302. PubMed ID: 26100618
    [Abstract] [Full Text] [Related]

  • 2. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
    Troyanov Y, Targoff IN, Payette MP, Raynauld JP, Chartier S, Goulet JR, Bourré-Tessier J, Rich E, Grodzicky T, Fritzler MJ, Joyal F, Koenig M, Senécal JL.
    Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
    [Abstract] [Full Text] [Related]

  • 3. Paraneoplastic Dermatomyositis in a Patient with Metastatic Gastric Carcinoma.
    Pozharashka J, Dourmishev L, Rusinova D, Balabanova M, Miteva L.
    Acta Dermatovenerol Croat; 2020 Aug; 28(2):120-122. PubMed ID: 32876041
    [Abstract] [Full Text] [Related]

  • 4. Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry.
    Hum RM, Lilleker JB, Lamb JA, Oldroyd AGS, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Danieli MG, Oakley P, Griger Z, Nguyen Thi Phuong T, Kodishala C, Vazquez-Del Mercado M, Andersson H, De Paepe B, De Bleecker JL, Maurer B, McCann L, Pipitone N, McHugh N, New RP, Ollier WE, Krogh NS, Vencovsky J, Lundberg IE, Chinoy H, MYONET Registry .
    Rheumatology (Oxford); 2024 Aug 01; 63(8):2093-2100. PubMed ID: 37698987
    [Abstract] [Full Text] [Related]

  • 5. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
    Girard C, Vincent T, Bessis D.
    Ann Dermatol Venereol; 2013 Oct 01; 140(10):628-34. PubMed ID: 24090894
    [Abstract] [Full Text] [Related]

  • 6. [Anti-MDA5 dermatomyositis. Literature review].
    Castro-Molina SA, Méndez-Flores S.
    Rev Med Inst Mex Seguro Soc; 2023 Jan 02; 61(1):99-105. PubMed ID: 36542793
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antimelanoma Differentiation-associated Gene 5 Antibody: Expanding the Clinical Spectrum in North American Patients with Dermatomyositis.
    Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R.
    J Rheumatol; 2017 Mar 02; 44(3):319-325. PubMed ID: 28089977
    [Abstract] [Full Text] [Related]

  • 9. Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.
    Merlo G, Clapasson A, Cozzani E, Sanna L, Pesce G, Bagnasco M, Burlando M, Parodi A.
    Arch Dermatol Res; 2017 Mar 02; 309(2):87-95. PubMed ID: 27928683
    [Abstract] [Full Text] [Related]

  • 10. Ulcerative Heliotrope Rash in Antimelanoma Differentiation-Associated Gene 5 Dermatomyositis.
    Daugherty TT, Cheeley JT.
    Cutis; 2021 May 02; 107(5):E5-E8. PubMed ID: 34288860
    [Abstract] [Full Text] [Related]

  • 11. The clinical features, diagnosis and classification of dermatomyositis.
    Iaccarino L, Ghirardello A, Bettio S, Zen M, Gatto M, Punzi L, Doria A.
    J Autoimmun; 2014 May 02; 48-49():122-7. PubMed ID: 24467910
    [Abstract] [Full Text] [Related]

  • 12. Disease characteristics and clinical outcomes of adults and children with anti-MDA-5 antibody-associated myositis: a prospective observational bicentric study.
    Dunga SK, Kavadichanda C, Gupta L, Naveen R, Agarwal V, Negi VS.
    Rheumatol Int; 2022 Jul 02; 42(7):1155-1165. PubMed ID: 34050793
    [Abstract] [Full Text] [Related]

  • 13. Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.
    Ueda-Hayakawa I, Hamaguchi Y, Okiyama N, Motegi S, Yamaoka T, Miyake S, Higashi A, Okamoto H, Takehara K, Fujimoto M.
    Br J Dermatol; 2019 Apr 02; 180(4):881-887. PubMed ID: 30120913
    [Abstract] [Full Text] [Related]

  • 14. Clinical presentation and evaluation of dermatomyositis.
    Marvi U, Chung L, Fiorentino DF.
    Indian J Dermatol; 2012 Sep 02; 57(5):375-81. PubMed ID: 23112358
    [Abstract] [Full Text] [Related]

  • 15. Anti-Mi-2 and Anti-TIF1-γ Double-Positive Juvenile Dermatomyositis Treated under Diagnosis of Chronic Eczema: A Case Report.
    Yoshida S, Matsumoto H, Fujita Y, Yokose K, Temmoku J, Matsuoka N, Yashiro-Furuya M, Asano T, Sato S, Suzuki E, Yago T, Yaguchi T, Aita T, Kusano M, Yamamoto T, Watanabe H, Migita K.
    Tohoku J Exp Med; 2022 Apr 20; 256(4):303-308. PubMed ID: 35296571
    [Abstract] [Full Text] [Related]

  • 16. Covert clues: the non-hallmark cutaneous manifestations of dermatomyositis.
    Castillo RL, Femia AN.
    Ann Transl Med; 2021 Mar 20; 9(5):436. PubMed ID: 33842657
    [Abstract] [Full Text] [Related]

  • 17. Dermatomyositis: Clinical features and pathogenesis.
    DeWane ME, Waldman R, Lu J.
    J Am Acad Dermatol; 2020 Feb 20; 82(2):267-281. PubMed ID: 31279808
    [Abstract] [Full Text] [Related]

  • 18. The association between clinical, subclinical features and autoantibody profile in Vietnamese dermatomyositis patients.
    Le MH, Dinh HT, Le TTH, Hoang PT, Vu MN, Le DH.
    PLOS Glob Public Health; 2023 Feb 20; 3(1):e0000979. PubMed ID: 36962887
    [Abstract] [Full Text] [Related]

  • 19. Clinical features of anti-TIF1-α antibody-positive dermatomyositis patients are closely associated with coexistent dermatomyositis-specific autoantibodies and anti-TIF1-γ or anti-Mi-2 autoantibodies.
    Muro Y, Ishikawa A, Sugiura K, Akiyama M.
    Rheumatology (Oxford); 2012 Aug 20; 51(8):1508-13. PubMed ID: 22539482
    [Abstract] [Full Text] [Related]

  • 20. The polymorphous spectrum of dermatomyositis: classic features, newly described skin lesions, and rare variants.
    Didona D, Juratli HA, Scarsella L, Eming R, Hertl M.
    Eur J Dermatol; 2020 Jun 01; 30(3):229-242. PubMed ID: 32666925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.